Catatonia Yesterday, Today, Tomorrow

Size: px
Start display at page:

Download "Catatonia Yesterday, Today, Tomorrow"

Transcription

1 Western University Psychiatry Presentations Psychiatry Department Catatonia Yesterday, Today, Tomorrow Amresh Srivastava University of Western Ontario, Follow this and additional works at: Part of the Psychiatry and Psychology Commons Citation of this paper: Srivastava, Amresh, "Catatonia Yesterday, Today, Tomorrow" (2007). Psychiatry Presentations

2 Catatonia Yesterday, today, tomorrow Amresh Shrivastava Assistant Professor University of western Ontario, London, Canada & Physician Team leader, Early psychosis Programme, RMHC- St.Thomas 15th, January 2007 Amresh Srivastava, 1

3 Disappearance vs.. re-emergence Challenging, High mortality Life-threatening Beyond psychiatry Offers interface with medicine and neurology Constantly evolving in understanding 52 publications in th, January 2007 Amresh Srivastava, 2

4 Catatonia: Case vintage. A 40-yr.old man treated for psychosis with antipsychotic and antimanic medications since age of 16, was attending a community clinic, and stabilized with lithiumand chlorpromazine therapy. Encouraged by stability of condition therapist prescribed olazapine. Within a few weeks patient again became psychotic. Perphanizine was prescribed, within a day he became febrile, mute and rigid. Hospitalized and diagnosed as NMS, transferred to tertiary care facility APD was discontinued, further treated with large doses of bromochriptine & dantrolene. Repetitive movements prompted diagnosis of epilepsy, so anticonvulsants were administered. Lorazepam prescribed in low dose controlled infrequent agitation but he remained mute and rigid, required total nursing care After few weeks he was unable to stand; hands and legs were in rigid, immobile posture. A gastrostomy was done to permit feeding, he developed pulmonary and bladder infection requiring antibiotics He spent four months in intensive medical care and after that a visiting consultant [psychiatrist] recommended lorazepam in high doses. When the daily dose was increased to 12mg he responded to commands and smiled at his parents, though he remained mute ECT was recommended but the hospital had no facility, so he was transferred When his mother was signing the consent for ECT she recalled that he had a similar episode of rigidity mutism and psychosis at 16 years of age and responded to ECT 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 3

5 Lorazepam was reduced to 6 mgs per day and bilateral ECT begun After 4 treatments he recognized his parents, vocalized, smiled, was less rigid and took oral feedings By 9 th treatment he was verbally responsive but 4 months of rigidity & forced bed rest had left him with limb contractures and such badly impaired movements that he was unable to stand or use his hands to feed himself. Both catatonia and psychosis were relived After 22 ECT he was transferred to rehabilitation center and 4 months later he was again able to walk, use his hands and care for himself. COMMENTS This patient s ordeal was prolonged by several clinical missteps. Persisting in a failed trial with bromocriptine and dantrolene was not correct Generally if an acutely ill patient has not improved substantially within 7-10 days of treatment, that treatment needs to be reconsidered and probably changed Catatonic features interfering with general medical health, even catatonic features attributed to antipsychotic drugs improve substantially within several days when properly treated For this patient inadequate nursing care allowed contractures to develop The unavailability of ECT at a tertiary care hospital was indefensible. A long ill catatonic patient with joint contractures was successfully treated with Acts. REFERENCE: Mashimo et al 1995 quoted in Catatonia by Fink and Taylor 2003 Cambridge University press; pp th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 4

6 Catatonia is one clinical condition which reminds us that patients do not follow books but books are written by following patients 15th, January 2007 Amresh Srivastava, 5

7 Catatonia: A life threatening condition. A syndrome Catatonia is currently considered to be a psychomotor syndrome Remarkable constellation of motor and behavioral signs and symptoms that often occurs in relation to neuromedical insults. Structural brain lesions, intrinsic brain disease, and other systemic disorders that affect the brain, as well as idiopathic psychiatric disorders have been found to be associated 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 6

8 Catatonia: Historical evolution Catatonia or tension Insanity- Kahibaum 1874 Catatonia-dementia praecox kraeplin 1899 Symptoms as manifestation of Freudian complexes-bleuer 1911 With MDP - kahlbaum 1874 Motility Psychosis-Wenicke 1900 Cycloid Motility psychosis- Kleist 1912 and leonhard 1957 Catatonic schizophrenia-a group of Cerebral System Disorder - Kleist 1923 In Childhood & adolescence- Raecke 1909 Catatonia & Hysteria-Charcot 1886 Catatonia & OCD-Bleuler 1911,Kruger 2000 It was also well known that it could occur secondary to neurological, toxic-metabolic and infectious etiologies. Identified exclusively with schizophrenia as late as DSM III/ III-R This limitation changed in DSM-IV. 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 7

9 Epidemiology ( definition & concept) 1.rates of catatonia- a) General psychiatric Condition hospitalized acute psychosis b) mood disorder % c) schizophrenia- 6% in 1850 & 0.5% in 1950 incidence of catatonia % decrease 28.8 change in diagnosis time scale % decrease in incidence at one site diagnosis 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 8

10 Nosology Motility psychosis Catatonic schizophrenias A- unsystemetic catatonic, schiz, periodic catatonia B-systematic- schizophrenias 1.Para kinetic 2.mannerist Pros kinetic Negativistic Speech prompt Speech inactive Nosologic validity continues to be debated Concept & descriptive psychopathology-still insufficient Study of catatonia can be advanced by-- Adopt the approach of catatonia across psychiatric illness Reject notion of subtype or modifier Postulate as separate entity 15th, January 2007 Amresh Srivastava, 9

11 Current phenomenological classification As per DSM-IV; Now it is categorized as Catatonic disorder due to general medical condition Mood disorder with catatonic features The catatonic type of schizophrenia. Historically, Pre and post neuroleptic era has been found strongly associated with incidence of catatonia. Psychogenic catatonia Neuroleptic induced catatonia -NMS [ catatonia preceding NL administration and developing into NMS] Are possibly most suitable clinical classification. 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 10

12 Catatonia in psychiatric classification: the evidence Catatonia is a condition qualifying for finding its own place in various diagnostic systems. Because:- Catatonia is common Is Identified as a syndrome Can be Delineation from other syndromes[ differential diagnosis] Catatonia is also known by by other names Known to have Good response to specific treatment Common causes of catatonia Mood disorder General medical and neurological conditions Non-affective psychosis Genetic form of catatonia 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 11

13 Proposed category for classification Max Fink & Taylor; 2003 DSM Code xxx.0 Catatonia Code.xxx.1 Nonmalignant catatonia Code.xxx.2 delirious catatonia Code.xxx.3 malignant catatonia,nms, serotonin syndrome Specifier Code.xxx.x1 secondary to mood disorder Code.xxx.x2 secondary to gen.med.condition Code.xxx.x3 secondary to neurological dis. Code.xxx.x4 secondary to psychiatric disorder 15th, January 2007 Amresh Srivastava, 12

14 Proposed diagnostic criteria Max Fink & Taylor; 2003 A.immobility,Mutism,or stupor of at least 1 hours duration,associated with at least one of the followings: catalepsy,autonomic obedience,or posturing,observed or elicited,on two or more occasions. B.in absence of immobility,mutism or stupor,at least two of the followings:stereotypy,echophenomena,catalepsy,aut onomic obedience,posturing,negativism,gagenthalten, ambitendency 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 13

15 Catatonia & NMS {NL induced catatonia}, a lethal and malignant syndrome with high mortality-nms : first description 1960 by Delay et al. Share a common pathophysiology,& clinical manifestation While most cases of catatonia do not meet criteria for NMS, all unequivocal cases of NMS appear to meet criteria for catatonia. Though the syndrome has been described in different times, there is remarkable amount of similarity 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 14

16 The classical features of catatonia: about 42 symptoms have been identified Catatonia has three groups of symptoms: motor symptoms behavioral symptoms emotional symptoms All three have different underlying pathophysiological mechanism Mutism Immobility Staring Posturing Negativism Withdrawal 15th, January 2007 Amresh Srivastava, 15

17 Subtypes and classification: Main subgroups are: Malignant and Non-malignant Catatonia Catatonic withdrawal Catatonic excitement Alternating Periodic [ excitement alternating with stuperous state] Lethal catatonia Catatonic stupor Malignant Simple - nonmalignant Pernicious NMS variants Clinical description, course and outcome 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 16

18 Catatonia : Idiopathic: without brain atrophy & -with brain atrophy Associated with bipolar disorder; major depression other affective disorder: schizophrenia; other psychiatric disorder [Psychogenic] Catatonia secondary to:( Medical Catatonia) TLE other Seizure Disorder brain tumor brain trauma encephalitis- post encephalitis state cerebro vascular diseases focal brain lesions akinetic mutism Parkinson's Toxic encephalopathy Metabolic encephalopathy Other medical disorders NMS Neuroleptics Other prescribed psychotropics Illicit psychotropics Phencyclidine exposure, SLE, Corticosteroids; disulfiram Porphyria 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 17

19 Assessment of catatonia by Braunig catatonia rating scale The scale contains 21 items (16-motor symptoms & 5 behavioral symptoms rated from 0-4) Motor excitement Verbigeration Stereotypis Motor inhibition Iteration Grouping Impulsivity Mutisim Grimacing Exaggerated responsiveness blinking Mannerism Gerky movements Genhalten Rigidity Negativism Parakinesis Postural Waxy flexibility Rituals Automatic obedience Mood disorder vs. schizophrenia 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 18

20 Catatonic spectrum disorders: depending upon shared neurobiology Lethal malignant catatonia - high mortality NL induced catatonia, NMS, Serotonin syndrome Classical catatonic stuperous state Various independent catatonic symptoms Catatonia variants Non-malignant simple catatonia Autism spectrum disorder 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 19

21 Incidence of catatonic schizophrenia in various countries 40% 35% 30% 25% has reduced over time due to several factors, generally observed in about 10-15% of psychiatric population;4% TO 10% IN ACADEMIC INPATIENT UNITS 20% 15% 10% 5% 0% Germany U.S. Germany U.S. U.S. U.S. U.S. India U.S. Countries 15th, January 2007 Amresh Srivastava, 20

22 Are we witnessing the disappearance of catatonic schizophrenia? Symptoms or syndrome.?? E.Bleuer 1991 >33 Kraepelin Mayor-Gross Leonhard Leonhard Astrup fish Huber Huber M.Bleuer Muller Warthen Morrison Kasper Strass Kane Stieglitz th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 21

23 feature Catatonia in depression motoric immobility stupor;extreme agitation;extreme negativism;posturing;stereotyped movements,mannerisms,or grimacing and echolalia or echopraxia treatment BZ with continued oral administration, When, no relief, urgent provision for ECT After catatonic symptoms are relieved Tx should continue with ADD,Lithium, APD or combination outcome Efficacy of ECT usually appears after few treatments, ECT may initially be administered daily 15th, January 2007 Amresh Srivastava, 22

24 features Catatonia in mania develop in 1/3 of patients. are--motor excitement,mutism,and stereotypic movements,patients exhibiting stupor may go on to show more typical signs of mania, greater episode severity,mixed states,and poorer short-term outcome, treatment outcome Lorazepam is effective, ECT is most effective,regardless of etiology,should be considered if BZ fails. NL generally have exhibited poor efficacy, Leonhard: 2 types of MDP with catatonic features;with or without catatonia;significantly differing on mean number of days in hospital 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 23

25 High risk or At-risk or Vulnerable for catatonia & poor prognosis Male gender Adolescent onset Presence of autistic traits Obstetric events Post-natal brain insult Soft neurological signs NL sensitivity Family history of catatonia Catatonia generally has good outcome but presence of catatonic symptom has poor prognosis of schizophrenia or mania 15th, January 2007 Amresh Srivastava, 24

26 NMS & its Risk factors Mortality has decreased from 20% to 10% and incidence has also decreased. Life time incidence - about 0.2% amongst antipsychotic users Hyperthermia and rabdomyolysis may lead to renal failure CPK rises dramatically [ even up to 60K units] Risk factors include:- Rapid dose escalation of HP, first generation APD Parenteral administration of APD Underlying neurological impairment NMS is probably less common with second generation APD than with first one. Incidence with first generation is low now possibly because of low dosage than in the past. Polypharmacy, concomitant anticholinergics,lithium 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 25

27 NMS & its Risk factors May be fatal, if untreated, Tx. Includes : temperature control by cooling,fluid correction,da agonist-bromcriptine 2.5 mg QDS, muscle relaxant, dantrolene mg/kg,iv 6 hourly ECT is indicated if catatonia related to NMS persists or response is inadequate with drugs, Need for APD should be carefully assessed, before resumption, When another trial of APD is attempted, second generation, particularly clozapine are preferred, A re-challenge should begin with low dose and slow titration 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 26

28 NMS variables Death Sequelae Full recovery N=17 N=10 N=22 age female 59% 60% 23% Psychomotor excitement 41% 60% 36% dehydration 54% 80% 64% Lithium 18% 30% 9% Antiparkinsons 76% 30% 77% I/M NL 35% 30% 14% Dose NL/day Loading dose NL/d dantrolene 59% 80% 59% bromcriptine 14% 30% 41% Max CPK 1000 IU/L th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 27 Max body temperature

29 Differential Diagnosis organic,psychogenic,drug induced, idiopathic, Idiopathic primary catatonia Secondary catatonia Lethal catatonia Catatonic excitement Diagnosis is essentially clinical supported by measurement and rating scales, Rule out other causes presents as emergency, move very quickly and systematically Often diagnosing catatonia in schizophrenia vs. mania is difficult at the beginning. 15th, January 2007 Amresh Srivastava, 28

30 Clinical dilemmas and challenges Very severe cases has less problem, Most of the difficulties arise in borderline cases. New contact : most would adopt rule out. Time length for definitive Tx is crucial Severe excitement is a management problem Partial syndromes only When diagnostic criteria is not fulfilled Presence of high fever and h/o NL Rapid cycling and periodic catatonia When response does not progressed 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 29

31 Clinical dilemmas and challenges When response does not sustain Frequent relapses Determining psychiatric diagnosis schizophrenia vs. mood disorder Presence of psychosis; Use Antipsychotic ; to be or not to be Should CSF be checked / routinely Deciding about ECT in medically compromised Therapeutic or service set up Issues of transfer Issues around consent and capacity 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 30

32 Clinical dilemmas and challenges Late onset, paediatric, in pregnancy Planning relapse prevention Which antipsychotic in catatonic Schizophrenia after termination with ECT and which MS and ADD in Bipolar Disorder? Virtually all APD typical or atypical have been known to cause NMS,Incipient NMS or its variants, including clozapine. All atypical APD have shown some degree of response in NMS and catatonia? Clinical guidelines are not clear and experience is the best guide. 15th, January 2007 Amresh Srivastava, 31

33 APA practice Guidelines there are at present no treatment strategies specific to the various subtypes [ of schizophrenia] with exception to the use of BZ for Catatonia In Mania use BZ and ECT In depression; concurrent ADD use and BZ with ECT, after catatonic features are relieved TX may be continued with ADD,Lithium,APD or a combination.. 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 32

34 Special conditions Catatonia-autism spectrum Catatonia in childhood and adolescence Late-onset catatonia Catatonia in liver transplant Post-partum catatonia Catatonia in co-morbid medical condition like hypertension 15th, January 2007 Amresh Srivastava, 33

35 Clinical advances Catatonia is an infrequent but severe condition in young people, and is usually associated with schizophrenia. Obstetric complications and neurological abnormalities in neuroleptic-naive psychotic patients. Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders. Shared susceptibility region on chromosome 15 between autism and catatonia. Classification matters for catatonia and autism in children. NMS in adolescents after brief exposure to olanzapine Catatonia in Alzheimer's Lewy body dementia after Donapezil Malignant and late onset catatonia Catatonia after single dose of ecstasy 15th, January 2007 Amresh Srivastava, 34

36 Relative Prognosis Best Better Good poor mood disorder without catatonia depression With catatonia periodic catatonia cycloid psychosis with catatonia Bipolar disorder with catatonia catatonic schizophr enia noncatat onic schizoph renia. 15th, January 2007 Amresh Srivastava, 35

37 Fundamental Problem A disorder of Motivation and Movement link Catatonic patients are well able to initiate movements, but they are apparently unable to terminate the movement once initiated in an appropriate way. In contrast to initiation, neural network study of underlying termination of movement has been neglected in the research to date. 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 36

38 All information put together, it appears that the Motor symptoms nigrostriatal, basal ganglia and motor cortex Emotional symptoms ---- prefrontal and limbic cortex Behavioral symptoms---mesolimbic cortex All three are interdependent because of circuits and loops which are closed within these structures. That there is a pre-existing brain insult present in vulnerable candidates 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 37

39 Various hypothesis have been proposed. Neurotransmitter hypothesis Universal field hypothesis Vulnerability theory because of brain structural changes Emotional-motor activation paradigm Motivation-movement paradigm Neurochemical: increased CPK and Low serum Iron Neuronal Circuits paradigm Restitutive dopamine hypothesis Top-down modulation : A Neuropsychiatric hypothesis: parallel from Parkinson's disease 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 38

40 Dopamine hypo-activity There is dysfunction in neurotransmission in cortical and subcortical areas. The dysfunction is a result of a combination of NT involvement. Leading NT involved are DA,GABA,5HT,NMDA There is hypofunction D2 activity in various cortical areas mesolimbic, nigrostriatal, motor, prefrontal and orbitofrontal areas Decreased D2 function is also found in caudate nucleus, nucleus accembens, palladium and thalamus. This hypothesis proposes that it is the interaction of these systems that predisposes, initiates, and maintains the twin syndromes of catatonia & NMS 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 39

41 Catatonia is a delicate balance between dopamine and Gaba neurons Major NT NMDA DA, GABA, NMDA, 5HT2a Gaba-A Gaba-B--ratio decreased 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 40

42 Gaba and major brain areas The ratio of GABA A and GABA B may play a role in development of catatonia. There is Hypo activity at GABA A receptor; Lorazepam, a GABA agonist is effective in catatonia Serotonin Hyperactivity at the 5-HT 1A receptor hypo activity at 5HT 2A receptor Glutamate Hypo function of NMDA Receptor Major Brain regions implicated in catatonia are: Limbic system - nucleus accumbens Thalamus Caudate nucleus Motor area Fronto-orbito cortex Right posterior parietal cortex Mesolimbic and mesostriatal cortex, 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 41

43 DA GABA 15th, January 2007 Amresh Srivastava, 42

44 catatonia Findings of brain imaging Structural changes Neuropathological findings Functional changes Caudate Nucleus:Palladium; nucleus accembens;thalamus shows Decreased cell density reduced activity in medial orbitofrontal cortex during negative emotional stimulation,suggesting possible initiation point. imaging and neuropsychology indicate a relationship between deficits in visual-constructive function & decreased rcbf in the right posterior parietal cortex, alteration in right posterior parietal function may count for the deficit in termination of movements responsible for motor symptoms of posturing. 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 43

45 Movement control In healthy individuals termination of movement involves. the right posterior parietal cortex because the registration. on line monitoring of the respective spatial position of the movement may be of central importance for an appropriate termination. Negative emotional processing in the right medial orbitofrontal cortex may be particularly altered in catatonia with an abnormal functional connectivity to the premotor/motor cortex 15th, January 2007 Amresh Srivastava, 44

46 Neuronal circuits and catatonia Cognitive,behavioral and emotional circuits Each circuit has cortico/limbic, striatal, pallidial/nigral, and thalamic nodal points with the loops closed by thalmocortical connections. Any neuromedical or psychiatric disturbance significant enough to disrupt the GABA-DA balance in the mesotriatal-mesocortocolimbic medial forebrain bundle of DA tracts with terminal fields in nucleus accumbens, the anterior cingualte, and the prefrontal cortex system anywhere along the circuitry will potentially set off a catatonic response. 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 45

47 15th, January 2007 Amresh Srivastava, 46

48 Dopamine restiturive hypothesis DAgic system in involved in protecting against the emergence of psychotic symptoms, DA-gic system then may stabilize mental homeostatic by spontaneous Down regulation of its own function In some patients, this down reg. is sufficient to maintain a non-psychotic state if the biological or psychological stresses are so severe that down regulation is not adequate to prevent psychosis. The syndrome appears Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity. Periodic catatonia is the first sub-phenotype of schizophrenic psychoses with confirmed linkage despite the existence of considerable genetic heterogeneity. 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 47

49 Top-down modulation : A Neuropsychiatric hypothesis Differential diagnosis of motor symptoms is difficult. Symptoms may have CNS origin [Parkinson's] or psychiatric [ catatonia] Despite differences in origin symptoms may appear similar Possibility of dissociation between origin and clinical appearance may reflect functional brain organization in general & cortical-cortical/subcortical in particular. hypothesized : similarities and differences between Parkinson's disease and catatonia - accounted for by distinct kind of modulation between cortico-cortical and cortico-subcortical relation. The different symptoms be accounted for by dysfunction in orbitofrontalprefrontal/parietal cortical connectivity reflecting horizontal modulation of cortical-cortical relation. reflecting vertical modulation of caudate and other BG by GABAergic mediated orbitofrontal cortical deficit may account for motor symptoms in catatonia. 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 48

50 Modulation OFC Pre Frontal - + Motor & Pre-motor cortex Horizontal BG Vertical Or Top-down 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 49

51 Issues about management Over time the mortality has decreased Needs emergency and multidisciplinary care Often requires Intensive care team Management focus has to be on 1. Establishing the diagnosis asap.2. Arrange supportive treatment,3.rule out secondary causes.4consider definitive treatment,all without loss of time Clinical presentation is rarely uncomplicated Duration of untreated illness is very high. 15th, January 2007 Amresh Srivastava, 50

52 Management Thus complications of nutritional deficiency,starvations, posturing, metabolic imbalance,infection,worm infestation,skin diseases,injury, cardiac complication,fever and toxemia are common. Thus management should address:- Vital functions, nutrition, hydration, correction of electrolyte,infection and other relevant condition, and Then proceed for definitive treatment with BZ,ECT etc. Fitness to anaesthesia and ECT is a crucial clinical issue. 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 51

53 Treatment options Electroconvulsive therapy and lately benzodiazepines are not only effective treatment options in this form of catatonia,but also helped generate neurobiological hypotheses concerning its pathophysiology LORAZEPAM IV CHALLENGE IF POSITIVE, LORAZEPAM ORAL. DOSAGES ARE HIGH MG/DAY ECT DAILY TREATMENT FOR 2-5 DAYS BILATERAL ELECTRODE PLACEMENT AVOID ANTIPSYCHOTIC DRUGS 15th, January 2007 Amresh Srivastava, 52

54 Catatonia rating Treatment of catatonia with IV lorazepam Prospective Study : Bush et at., DOSES AT 5 MIN INTERVAL N=9 0 0 BASELINE TX - 1 TX - 2 POS RESP NON RESP Ungvari : demonstrated that lorazepam was not effective in chronic states of catatonia, associated with chronic psychiatric conditions.---- suggesting that not all catatonia are lorazepam - responsive 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca POS RESP 2 NON RESP

55 Tx of associated Disorder.e.g. Psychotic/bipolar AATPD Catatonia Supportive & preventive measures Atypical APD Evidence from Case reports And retrospective chart Review Caution: NMS Non-Malignant Catatonia BZ low dose BZ High dose MC / NMS BZ/ ECT approach OR DA -muscle relaxant approach Stop classical antipsychotic No indication of atypical APD BZ High dose ECT ECT 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 54

56 Treatment of Catatonia A. simple catatonia(including NLinduced catatonia) Lorazepam Still catatonic DA Agonist Still catatonic ECT B.lethal catatonia (including NMS) Lorazepam And/or DA agonist +/- Dantrolene Still catatonic ECT - prior to 5 days Valproate for catatonia: need for caution in patients on SSRIs and antipsychotic. 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 55

57 Advances in management meantime, may be beneficial in catatonic schizophrenia due to a glutamatergic dysfunction present in catatonic patients. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index? Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report. Medical complications of catatonia: a case of catatonia-induced deep venous thrombosis. Gilles de la Tourette form of catatonia: response to ECT. Catatonia and transcranial magnetic stimulation. Lethal catatonia responding to high-dose olanzapine therapy. Lithium carbonate in prophylaxis of reappearing catatonic stupor: case report. Treatment of catatonic syndrome with fluoxetine. Case report] 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 56

58 Advances: future questions Nonconscious processing, anterior cingulate and catatonia Catatonia is not ready for unified theory Does catatonia has a specific brain biology What medical catatonia tell us about top down modulation Catatonia- a window into the cerebral underpinnings of will Catatonia-a disorder of motivation and movement Cognitive-motor deficit in catatonia 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 57

59 Finally, its clear that 1.our conceptualization of catatonia has changed over years away from a motor manifestation of schizophrenia and towards a motor,behavioural, emotional manifestation of mixed mania and many other organic disorders its patho-physiology continues to be a mystery. 3. however it is an important clinical syndrome and still continues to be life threatening condition in neuropsychiatry 15th, January 2007 Amresh Srivastava, asrivas9@uwo.ca 58

Schizophrenia FAHAD ALOSAIMI

Schizophrenia FAHAD ALOSAIMI Schizophrenia FAHAD ALOSAIMI MBBS, SSC - PSYCH C ONSULTATION LIAISON PSYCHIATRIST K ING SAUD UNIVERSITY Schizophrenia - It is not a single disease but a group of disorders with heterogeneous etiologies.

More information

Catatonia a forgotten but not extinct condition

Catatonia a forgotten but not extinct condition NACT meeting 2016 Catatonia a forgotten but not extinct condition Tom G. Bolwig Professor emeritus, dr.med University of Copenhagen What is Catatonia? Catatonia is a motor dysregulation syndrome among

More information

Schizophrenia and Related Psychotic Disorders

Schizophrenia and Related Psychotic Disorders and Related Psychotic Disorders Anand K. Pandurangi, MD Professor & Chair, Div. of Inpatient Psychiatry Director, Program VCU Medical Center 1 Kraeplin 1896 Dementia Praecox. Single, Homogenous Disorder

More information

Chapter 12. Schizophrenia and Other Psychotic Disorders. PSY 440: Abnormal Psychology. Rick Grieve Western Kentucky University

Chapter 12. Schizophrenia and Other Psychotic Disorders. PSY 440: Abnormal Psychology. Rick Grieve Western Kentucky University Chapter 12 Schizophrenia and Other Psychotic Disorders PSY 440: Abnormal Psychology Rick Grieve Western Kentucky University psychotic disorders disorders so severe that the person has essentially lost

More information

PRESCRIBING GUIDELINES

PRESCRIBING GUIDELINES The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors

More information

Psychotic Disorders. Schizophrenia. Age Distribution of Onset 2/24/2009. Schizophrenia. Hallmark trait is psychosis

Psychotic Disorders. Schizophrenia. Age Distribution of Onset 2/24/2009. Schizophrenia. Hallmark trait is psychosis Psychotic Disorders Schizophrenia Schizophrenia Affects people from all walks of life Is about as prevalent as epilepsy Usually begins in late adolescence or early adulthood Hallmark trait is psychosis

More information

Schizophrenia. Psychology 372 Physiological Psychology. Overview. Characterized by. Disorganized Thoughts Hallucinations Delusions Bizarre behaviors

Schizophrenia. Psychology 372 Physiological Psychology. Overview. Characterized by. Disorganized Thoughts Hallucinations Delusions Bizarre behaviors Overview Schizophrenia Psychology 372 Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides Probably consists of more than one disorder Is the most devastating

More information

4. General overview Definition

4. General overview Definition 4. General overview 4.1. Definition Schizophrenia is a severe psychotic mental disorder characterized by significant disturbances of mental functioning. It has also been called early dementia, intrapsychic

More information

NATALIE D. WEDER, MD, SUNANDA MURALEE, MD, HEATH PENLAND, MD, and RAJESH R. TAMPI, MD, MS

NATALIE D. WEDER, MD, SUNANDA MURALEE, MD, HEATH PENLAND, MD, and RAJESH R. TAMPI, MD, MS Annals of Clinical Psychiatry, 20[2]:97 107, 2008 Copyright American Academy of Clinical Psychiatrists ISSN: 1040-1237 print / 1547-3325 online DOI: 10.1080/10401230802017092 Catatonia: A Review UACP Catatonia:

More information

Tracey G. Skale, MD Chief Medical Officer Greater Cincinnati Behavioral Health

Tracey G. Skale, MD Chief Medical Officer Greater Cincinnati Behavioral Health Schizophrenia: What Do We Know? Where Do We Go From Here? Tracey G. Skale, MD Chief Medical Officer Greater Cincinnati Behavioral Health Objectives Participants will be able to: Understand the clinical

More information

Comparison of Catatonia Presentation in Patients with Schizophrenia and Mood Disorders in Lagos, Nigeria. Original Article

Comparison of Catatonia Presentation in Patients with Schizophrenia and Mood Disorders in Lagos, Nigeria. Original Article Original Article Comparison of Catatonia Presentation in Patients with Schizophrenia and Mood Disorders in Lagos, Nigeria Dada Mobolaji Usman, MBChB, MSc (Epid), FMCPsy 1 Okewole Adeniran Olubunmi, MBBS

More information

Schizophrenia. Psychotic Disorders. Schizophrenia. Chapter 13

Schizophrenia. Psychotic Disorders. Schizophrenia. Chapter 13 Schizophrenia Chapter 13 Psychotic Disorders Symptoms Alternations in perceptions, thoughts, or consciousness (delusions and hallucination) DSM-IV categories Schizophrenia Schizophreniform disorder Schizoaffective

More information

Elements for a Public Summary. VI.2.1 Overview of disease epidemiology

Elements for a Public Summary. VI.2.1 Overview of disease epidemiology VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Schizophrenia Schizophrenia is a mental disorder often characterized by abnormal social behaviour and failure to recognize what

More information

Are they still doing that?

Are they still doing that? Are they still doing that? Why we still give ECT and when to refer Nicol Ferrier BSc (Hons), MD, FRCP(Ed), FRCPsych Emeritus Professor of Psychiatry Newcastle University Rates of prescribing ECT in the

More information

Psychotropic Drugs 0, 4-

Psychotropic Drugs 0, 4- 0, 4- } -v Psychotropic Drugs NORMAN L. KELTNER, Ed D, RN Associate Professor, Graduate Program, University of Alabama School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama DAVID

More information

Study Guide Unit 3 Psych 2022, Fall 2003

Study Guide Unit 3 Psych 2022, Fall 2003 Psychological Disorders: General Study Guide Unit 3 Psych 2022, Fall 2003 1. What are psychological disorders? 2. What was the main treatment for some psychological disorders prior to the 1950 s? 3. What

More information

Psychopathology: Biological Basis of Behavioral Disorders

Psychopathology: Biological Basis of Behavioral Disorders 1 6 Psychopathology: Biological Basis of Behavioral Disorders 16 Psychopathology: Biological Basis of Behavioral Disorders The Toll of Psychiatric Disorders Is Huge Schizophrenia is the major neurobiological

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

The Maudsley Prescribing Guidelines in

The Maudsley Prescribing Guidelines in The Maudsley Prescribing Guidelines in 11th Edition David Taylor Director of Pharmacy and Pathology South London and Maudsley NHS Foundation Trust; Professor King's College London, London, UK Paton Chief

More information

Dr. Fred Rose. Schizophrenia. Nature of Schizophrenia and Psychosis: An Overview. Prevalence of Schizophrenia 10/20/10. Schizophrenia vs.

Dr. Fred Rose. Schizophrenia. Nature of Schizophrenia and Psychosis: An Overview. Prevalence of Schizophrenia 10/20/10. Schizophrenia vs. Schizophrenia Dr. Fred Rose Nature of Schizophrenia and Psychosis: An Overview Schizophrenia vs. Psychosis Psychosis Cluster of disorders; hallucinations and/or loss of contact with reality Schizophrenia

More information

VO- PMHP Treatment Guideline 102: Electroconvulsive Therapy (ECT)

VO- PMHP Treatment Guideline 102: Electroconvulsive Therapy (ECT) VO- PMHP Treatment Guideline 102: Electroconvulsive Therapy (ECT) Diagnostic Guidelines: Introduction: Electroconvulsive Therapy has been in continuous use for more than 60 years. The clinical literature

More information

Chapter Sixteen. Psychological Disorders

Chapter Sixteen. Psychological Disorders Chapter Sixteen Psychological Disorders Prevalence of Psychological Disorders? Approximately 25% of the Adult Population here in the U.S. of A. Higher percentages in areas / countries with high poverty

More information

On Catatonia and Dementia: A Case Report

On Catatonia and Dementia: A Case Report http://escholarship.umassmed.edu/neurol_bull On Catatonia and Dementia: A Case Report Jordan Eisenstock Department of Neurology University of Massachusetts Memorial Medical Center, Worcester, MA The many

More information

Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics

Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics John Donoghue Liverpool L imagination est plus important que le savoir Albert Einstein Switching Antipsychotics: Objectives

More information

Successful treatment of catatonic syndrome in bipolar I disorder adding aripiprazole to ECT: A case report

Successful treatment of catatonic syndrome in bipolar I disorder adding aripiprazole to ECT: A case report Eur. J. Psychiat. Vol. 26, N. 3, (169-173) 2012 Short report Keywords: Catatonia; Aripiprazole; Second generation antipsychotics; ECT; Bipolar disorder. Successful treatment of catatonic syndrome in bipolar

More information

Chapter 12 1/29/2018. Schizophrenia and Schizophrenia Spectrum Disorders. Epidemiology. Comorbidity. Lifetime prevalence of schizophrenia is 1%

Chapter 12 1/29/2018. Schizophrenia and Schizophrenia Spectrum Disorders. Epidemiology. Comorbidity. Lifetime prevalence of schizophrenia is 1% Chapter 12 Schizophrenia and Schizophrenia Spectrum Disorders Epidemiology Lifetime prevalence of schizophrenia is 1% No difference related to 2 Comorbidity Substance abuse disorders Anxiety, depression,

More information

Catatonia in a Tertiary Care Center in Eastern Part of Nepal: A Descriptive Study

Catatonia in a Tertiary Care Center in Eastern Part of Nepal: A Descriptive Study ORIGINAL ARTICLE Catatonia in a Tertiary Care Center in Eastern Part of Nepal: A Descriptive Study Adhikari BR 1, Subedi S 2, Joshi RG 1, Thapa A 1 1.Department of Psychiatry, BPKIHS, Dharan, Nepal 2.

More information

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D.

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D. HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D. Professor of Psychiatry, Neurology, and Pediatrics University of Iowa, Iowa City, Iowa The information provided

More information

Dementia With A Twist

Dementia With A Twist Dementia With A Twist Christina Tieu Geriatric Update for the Primary Care Provider November 17 th, 2016 2016 MFMER slide-1 79 y/o woman originally from Greece CC: paranoia, abulia and mutism Accompanied

More information

Schizophrenia & the Antipsychotics

Schizophrenia & the Antipsychotics splitting of mind (cognition/emotion) from reality 1% of population globally shamans or mentally ill Several subtypes: paranoid / catatonic / disorganized / undifferentiated / residual positive ( exaggerated)

More information

Rapid Relief of Catatonia in Mood Disorder by Lorazepam and Diazepam. Yu Chi Huang, Chin Chuen Lin, Yi Yung Hung, Tiao Lai Huang

Rapid Relief of Catatonia in Mood Disorder by Lorazepam and Diazepam. Yu Chi Huang, Chin Chuen Lin, Yi Yung Hung, Tiao Lai Huang Original Article Rapid Relief of Catatonia in Mood Disorder by Lorazepam and Diazepam Yu Chi Huang, Chin Chuen Lin, Yi Yung Hung, Tiao Lai Huang Background: Catatonia has risks of severe morbidity and

More information

ESSENTIAL PSYCHOPHARMACOLOGY, Neurobiology of Schizophrenia Carl Salzman MD Montreal

ESSENTIAL PSYCHOPHARMACOLOGY, Neurobiology of Schizophrenia Carl Salzman MD Montreal ESSENTIAL PSYCHOPHARMACOLOGY, 2011 Neurobiology of Schizophrenia Carl Salzman MD Montreal EVOLVING CONCEPTS OF SCHIZOPHRENIA Psychotic illness with delusions, hallucinations, thought disorder and deterioration;

More information

Schizophrenia and Other Psychotic Disorders

Schizophrenia and Other Psychotic Disorders Schizophrenia and Other Psychotic Disorders Chapter 14 This multimedia product and its contents are protected under copyright law. The following are prohibited by law: any public performance or display,

More information

Biological Risk Factors

Biological Risk Factors Biological Risk Factors Ms Angelina Crea Provisional Psychologist Academic Child Psychiatry Unit Royal Children s Hospital Professor Alasdair Vance Head Academic Child Psychiatry Department of Paediatrics

More information

Week #1 Classification & Diagnosis

Week #1 Classification & Diagnosis Week #1 Classification & Diagnosis 3 Categories in the Conceptualisation of Abnormality Psychological Dysfunction: Refers to a breakdown in cognitive, emotional or behavioural functioning. Knowing where

More information

Aging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health

Aging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health Aging with Bipolar Disorder Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health Objectives Define bipolar disorder in the elderly Review comorbidities How does it differ from bipolar in

More information

Contemporary Psychiatric-Mental Health Nursing. Psychopharmacology. Psychopharmacology - continued. Chapter 7 The Science of Psychopharmacology

Contemporary Psychiatric-Mental Health Nursing. Psychopharmacology. Psychopharmacology - continued. Chapter 7 The Science of Psychopharmacology Contemporary Psychiatric-Mental Health Nursing Chapter 7 The Science of Psychopharmacology Psychopharmacology A primary treatment mode of psychiatric-mental health nursing care Psychopharmacology - continued

More information

Chapter 161 Antipsychotics

Chapter 161 Antipsychotics Chapter 161 Antipsychotics Episode Overview Extrapyramidal syndromes are a common complication of antipsychotic medications. First line treatment is benztropine or diphenhydramine. Lorazepam is used in

More information

Schizophrenia and the Psychoses

Schizophrenia and the Psychoses Schizophrenia and the Psychoses Taking leave of one s senses Students of schizophrenia need to study and understand: Clinical presentation via case studies Terms and Definitions Biological features Prognosis

More information

The psychological disorders

The psychological disorders The psychological disorders Defining abnormal Statistical infrequency Normal distribution; the normal curve Violation of norms Culture bound syndromes Personal distress Some disorders do not involve distress

More information

Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com

Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com Introduction Psychotic spectrum disorders include schizotypal personality disorder, delusional disorder, brief psychotic

More information

Diagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder: evidence for the efficacy of atypical

Diagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder: evidence for the efficacy of atypical Diagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder: evidence for the efficacy of atypical antipsychotics 1 Abstract Acute agitation and aggression

More information

Affective Disorders.

Affective Disorders. Affective Disorders http://www.bristol.ac.uk/medicalschool/hippocrates/psychethics/ Affective Disorders Depression Mania / Hypomania Bipolar mood disorder Recurrent depression Persistent mood disorders

More information

THIOTHIXENE. THERAPEUTICS Brands Navane see index for additional brand names. Generic? Yes

THIOTHIXENE. THERAPEUTICS Brands Navane see index for additional brand names. Generic? Yes THIOTHIXENE THERAPEUTICS Brands Navane see index for additional brand names Generic? Yes Class Conventional antipsychotic (neuroleptic, thioxanthene, dopamine 2 antagonist) Commonly Prescribed for (bold

More information

The Neurobiology of Mood Disorders

The Neurobiology of Mood Disorders The Neurobiology of Mood Disorders J. John Mann, MD Professor of Psychiatry and Radiology Columbia University Chief, Department of Neuroscience, New York State Psychiatric Institute Mood Disorders are

More information

Brief Notes on the Mental Health of Children and Adolescents

Brief Notes on the Mental Health of Children and Adolescents Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems

More information

COALINGA STATE HOSPITAL. Effective Date: August 31, 2006

COALINGA STATE HOSPITAL. Effective Date: August 31, 2006 COALINGA STATE HOSPITAL NURSING POLICY AND PROCEDURE MANUAL SECTION Emergency Procedures POLICY NUMBER: 717 Effective Date: August 31, 2006 SUBJECT: NEUROLEPTIC MALIGNANT SYNDROME 1. PURPOSE: To provide

More information

Final Exam PSYC2022. Fall (1 point) True or False. The DSM-IV describes the symptoms of acute intoxication with cannabis.

Final Exam PSYC2022. Fall (1 point) True or False. The DSM-IV describes the symptoms of acute intoxication with cannabis. Final Exam PSYC2022 Fall 1998 (2 points) Give 2 reasons why it is important for psychological disorders to be accurately diagnosed. (1 point) True or False. The DSM-IV describes the symptoms of acute intoxication

More information

Common poly-substance abuse: MDMA, Ketamine, & Methamphetamine Clinical detection and management

Common poly-substance abuse: MDMA, Ketamine, & Methamphetamine Clinical detection and management Common poly-substance abuse: MDMA, Ketamine, & Methamphetamine Clinical detection and management Prepared by Dr. S.P. LEUNG Castle Peak Hospital 27th January 2001 Medical practitioner should provide care

More information

Huntington s Disease Psychiatry. Christopher A. Ross MD PhD HDSA Convention June 6, Many slides adapted from Adam Rosenblatt, MD

Huntington s Disease Psychiatry. Christopher A. Ross MD PhD HDSA Convention June 6, Many slides adapted from Adam Rosenblatt, MD Huntington s Disease Psychiatry Christopher A. Ross MD PhD HDSA Convention June 6, 2008 --Many slides adapted from Adam Rosenblatt, MD Huntington s Disease Society of America The information provided by

More information

What catatonia can tell us about top-down modulation : A neuropsychiatric hypothesis

What catatonia can tell us about top-down modulation : A neuropsychiatric hypothesis BEHAVIORAL AND BRAIN SCIENCES (2002) 25, 555 604 Printed in the United States of America What catatonia can tell us about top-down modulation : A neuropsychiatric hypothesis Georg Northoff Laboratory for

More information

Program Outline. DSM-5 Schizophrenia Spectrum and Psychotic Disorders: Knowing it Better and Improving Clinical Practice.

Program Outline. DSM-5 Schizophrenia Spectrum and Psychotic Disorders: Knowing it Better and Improving Clinical Practice. DSM-5 Spectrum and Disorders: Knowing it Better and Improving Clinical Practice Rajiv Tandon, MD Professor of Psychiatry University of Florida College of Medicine Gainesville, Florida Program Outline Changes

More information

SCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry 2 Practical # 2

SCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry 2 Practical # 2 Psychiatrická klinika LFUK a UNB, Bratislava SCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry 2 Practical # 2 Author: MUDr. Ľubomíra Izáková, PhD. Supervisor: doc. MUDr. Ján Pečeňák, CSc. Podporené grantom

More information

The Neurobiology of Addiction

The Neurobiology of Addiction The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly

More information

Delirium & Dementia. Nicholas J. Silvestri, MD

Delirium & Dementia. Nicholas J. Silvestri, MD Delirium & Dementia Nicholas J. Silvestri, MD Outline Delirium vs. Dementia Neural pathways relating to consciousness Encephalopathy Stupor Coma Dementia Delirium vs. Dementia Delirium Abrupt onset Lasts

More information

Νευροφυσιολογία και Αισθήσεις

Νευροφυσιολογία και Αισθήσεις Biomedical Imaging & Applied Optics University of Cyprus Νευροφυσιολογία και Αισθήσεις Διάλεξη 19 Ψυχασθένειες (Mental Illness) Introduction Neurology Branch of medicine concerned with the diagnosis and

More information

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.

More information

Anatomy of the basal ganglia. Dana Cohen Gonda Brain Research Center, room 410

Anatomy of the basal ganglia. Dana Cohen Gonda Brain Research Center, room 410 Anatomy of the basal ganglia Dana Cohen Gonda Brain Research Center, room 410 danacoh@gmail.com The basal ganglia The nuclei form a small minority of the brain s neuronal population. Little is known about

More information

Olanzapine and ECT combined therapy in a refractory catatonic subtype schizophrenia. Pedro Gomes de Alvarenga* Sérgio Paulo Rigonatti**

Olanzapine and ECT combined therapy in a refractory catatonic subtype schizophrenia. Pedro Gomes de Alvarenga* Sérgio Paulo Rigonatti** Case report Olanzapine and ECT combined therapy in a refractory catatonic subtype schizophrenia patient with previous neuroleptic malignant syndrome episodes Pedro Gomes de Alvarenga* Sérgio Paulo Rigonatti**

More information

Modulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder

Modulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder BRAIN STIMULATION LABORATORY Modulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder OCD Awareness Day NOLAN WILLIAMS, M.D. Instructor Department of Psychiatry Stanford University October

More information

ACADEMY OF PSYCHOSOMATIC MEDICINE Psychiatrists Providing Collaborative Care Bridging Physical and Mental Health

ACADEMY OF PSYCHOSOMATIC MEDICINE Psychiatrists Providing Collaborative Care Bridging Physical and Mental Health Catatonia in Medically Ill: Trends and Novel Approaches Kamalika Roy MD Oregon Health and Science University, Portland, OR Oregon State Hospital, Salem, OR ACADEMY OF PSYCHOSOMATIC MEDICINE Psychiatrists

More information

Behavior Therapy. Therapy that applies learning principles to the elimination of unwanted behaviors.

Behavior Therapy. Therapy that applies learning principles to the elimination of unwanted behaviors. Behavior Therapy Therapy that applies learning principles to the elimination of unwanted behaviors. To treat phobias or sexual disorders, behavior therapists do not delve deeply below the surface looking

More information

Risperidone as a Janus in Mood Disorder

Risperidone as a Janus in Mood Disorder KISEP Review Clinical Psychopharmacology and Neuroscience 2003; 1: 7-21 Risperidone as a Janus in Mood Disorder Doh Joon Yoon - Key points KEY WORDS: INTRODUCTION Address for correspondence: - - - - Risperidone

More information

TOWARDS A CLINICAL METHODOLOGY FOR NEUROPSYCHOPHARMACOLOGICAL RESEARCH

TOWARDS A CLINICAL METHODOLOGY FOR NEUROPSYCHOPHARMACOLOGICAL RESEARCH TOWARDS A CLINICAL METHODOLOGY FOR NEUROPSYCHOPHARMACOLOGICAL RESEARCH Development of Neuropsychopharmacology 1950s PHARMACOTHERAPY (1952-1957) PSYCHOPHARMACOLOGY NEUROTRANSMITTERS (1952-1960) SPECTROPHOTOFLUORIMETER

More information

Curriculum Vitae, Michael J. Downing, M.D.

Curriculum Vitae, Michael J. Downing, M.D. CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Alliance Director Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com PROFESSIONAL AFFILIATIONS: Michael

More information

GOALS FOR THE PSCYHIATRY CLERKSHIP

GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS - The aim of the core psychiatry clerkship is to expose students to patients with mental illness and to prepare them to provide psychiatric care at a basic level.

More information

Retrospective chart review of catatonia in child and adolescent psychiatric patients

Retrospective chart review of catatonia in child and adolescent psychiatric patients Acta Psychiatr Scand 2012: 125: 33 38 All rights reserved DOI: 10.1111/j.1600-0447.2011.01778.x Ó 2011 John Wiley & Sons A/S ACTA PSYCHIATRICA SCANDINAVICA Retrospective chart review of catatonia in child

More information

Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI

Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT

More information

Severe Selective Mutism in a Young Individual with Schizophrenia

Severe Selective Mutism in a Young Individual with Schizophrenia Severe Selective Mutism in a Young Individual with Schizophrenia William Frizzell, BA 1 ; Stephen Brasseux, MD 1,2 1 University of Arkansas for Medical Sciences, Little Rock, AR 2 Department of Psychiatry,

More information

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least

More information

Making Things Happen 2: Motor Disorders

Making Things Happen 2: Motor Disorders Making Things Happen 2: Motor Disorders How Your Brain Works Prof. Jan Schnupp wschnupp@cityu.edu.hk HowYourBrainWorks.net On the Menu in This Lecture In the previous lecture we saw how motor cortex and

More information

The New Clinical Science of ECT

The New Clinical Science of ECT The New Clinical Science of ECT C. Edward Coffey, MD Professor of Psychiatry & Behavioral Sciences, and of Neurology Baylor College of Medicine Houston, Texas Fellow and Past President, International Society

More information

Psychology 320: Topics in Physiological Psychology Lecture Exam 2: March 19th, 2003

Psychology 320: Topics in Physiological Psychology Lecture Exam 2: March 19th, 2003 Psychology 320: Topics in Physiological Psychology Lecture Exam 2: March 19th, 2003 Name: Student #: BEFORE YOU BEGIN!!! 1) Count the number of pages in your exam. The exam is 8 pages long; if you do not

More information

Extrapyramidal Symptoms Associated with Antipsychotic Use

Extrapyramidal Symptoms Associated with Antipsychotic Use Extrapyramidal Symptoms Associated with Antipsychotic Use Tamara Pringsheim, MD, FRCPC, FAAN Associate Professor, University of Calgary Department of Clinical Neurosciences, Psychiatry, Pediatrics and

More information

Treatments for Schizophrenia

Treatments for Schizophrenia Early treatments Treatments for Schizophrenia Psychology 311 Abnormal Psychology Trephining Open a hole in the skull Let out the evil spirit Some people even survived, had multiple holes with different

More information

POLYPHARMACY : FOR AND AGAINST NZMA GP CONFERENCE 2012 PSYCHOPHARMACOLOGY SERIES. Guna Kanniah Waikato Hospital

POLYPHARMACY : FOR AND AGAINST NZMA GP CONFERENCE 2012 PSYCHOPHARMACOLOGY SERIES. Guna Kanniah Waikato Hospital POLYPHARMACY : FOR AND AGAINST NZMA GP CONFERENCE 212 PSYCHOPHARMACOLOGY SERIES Guna Kanniah Waikato Hospital POLYPHARMACY FIVE REASONS FOR POLYPHARMACY 1. To treat a concomitant disorder 2. To treat an

More information

Professor Tony Holland, Department of Psychiatry, University of Cambridge

Professor Tony Holland, Department of Psychiatry, University of Cambridge INFORMATION SHEET The Use of Medication for Challenging Behaviour Professor Tony Holland, Department of Psychiatry, University of Cambridge Introduction Challenging behaviours displayed by people with

More information

TRI-STATE WEBINAR SERIES Catatonia and ASD: Hidden in Plain Sight

TRI-STATE WEBINAR SERIES Catatonia and ASD: Hidden in Plain Sight TRI-STATE WEBINAR SERIES Catatonia and ASD: Hidden in Plain Sight Ruth Aspy, Ph.D. and Barry G. Grossman, Ph.D. The Ziggurat Group Tri-State Autism Spectrum Disorder Webinar Series This material was developed

More information

The Brain on ADHD. Ms. Komas. Introduction to Healthcare Careers

The Brain on ADHD. Ms. Komas. Introduction to Healthcare Careers The Brain on ADHD Ms. Komas Introduction to Healthcare Careers Ms. Komas Period 9/2/2016 Komas 1 HOOK: Attention Deficit Hyperactivity Disorder (ADHD) plagues between 5% and 7% of children and less than

More information

DISEASES AND DISORDERS

DISEASES AND DISORDERS DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related

More information

Schizophrenia: New Concepts for Therapeutic Discovery

Schizophrenia: New Concepts for Therapeutic Discovery Schizophrenia: New Concepts for Therapeutic Discovery William T. Carpenter, M.D. Professor of Psychiatry and Pharmacology University of Maryland School of Medicine Department of Psychiatry Maryland Psychiatric

More information

NEUROPSYCHOLOGY TRACK COORDINATOR: Dr. Ellen Vriezen

NEUROPSYCHOLOGY TRACK COORDINATOR: Dr. Ellen Vriezen NEUROPSYCHOLOGY TRACK COORDINATOR: Dr. Ellen Vriezen The Neuropsychology Track offers two Resident Positions: NMS Code Number: 181516 1 position with an Adult emphasis, which provide training for residents

More information

9/3/2014. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd)

9/3/2014. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd) Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 16 Schizophrenia Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties, but can be as

More information

Review: Psychosocial assessment and theories of development from N141 and Psych 101

Review: Psychosocial assessment and theories of development from N141 and Psych 101 Unit III Theory and Practice of Psychiatric Nursing REQUIRED READINGS AND ACTIVITIES Related Activities Assignments Review: Psychosocial assessment and theories of development from N141 and Psych 101 Anxiety,

More information

SMI and SED Qualifying Diagnoses Table

SMI and SED Qualifying Diagnoses Table 295.00 Simple Type Schizophrenia, Unspecified State 295.01 Simple Type Schizophrenia, Subchronic State 295.02 Simple Type Schizophrenia, Chronic State 295.03 Simple Type Schizophrenia, Subchronic State

More information

8/22/2016. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd)

8/22/2016. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd) Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 16 Schizophrenia Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties, but can be as

More information

La catatonia nei pazienti bipolari: caratteristiche cliniche e risposta alla TEC. Pierpaolo Medda e Giulio Perugi AUOP, DMCS, Pisa, Italy

La catatonia nei pazienti bipolari: caratteristiche cliniche e risposta alla TEC. Pierpaolo Medda e Giulio Perugi AUOP, DMCS, Pisa, Italy La catatonia nei pazienti bipolari: caratteristiche cliniche e risposta alla TEC Pierpaolo Medda e Giulio Perugi AUOP, DMCS, Pisa, Italy Catatonia is a neuropsychiatric syndrome characterized by motor

More information

Clinical Guideline for the Management of Bipolar Disorder in Adults

Clinical Guideline for the Management of Bipolar Disorder in Adults Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:

More information

A. General features of the basal ganglia, one of our 3 major motor control centers:

A. General features of the basal ganglia, one of our 3 major motor control centers: Reading: Waxman pp. 141-146 are not very helpful! Computer Resources: HyperBrain, Chapter 12 Dental Neuroanatomy Suzanne S. Stensaas, Ph.D. March 1, 2012 THE BASAL GANGLIA Objectives: 1. What are the main

More information

DEMENTIA AND MEDICATION

DEMENTIA AND MEDICATION DEMENTIA AND MEDICATION Dr. Siobhan Ni Bhriain, MRCP, MRCPsych. Clinical Director, Tallaght and SJH MHS, Consultant Old Age Psychiatrist, Chair, DSIDC Steering Committee. SUMMARY OF TODAY S TALK Dementia-definition,

More information

E-BOOK MEDICAL CAUSES OF BIPOLAR DISORDER

E-BOOK MEDICAL CAUSES OF BIPOLAR DISORDER 28 February, 2018 E-BOOK MEDICAL CAUSES OF BIPOLAR DISORDER Document Filetype: PDF 507.23 KB 0 E-BOOK MEDICAL CAUSES OF BIPOLAR DISORDER Consult a doctor or other health care professional for diagnosis

More information

Disease Modification in Schizophrenia: Overview of the Issues. ISCTM February 18 th 2014 Ravi Anand, MD Switzerland

Disease Modification in Schizophrenia: Overview of the Issues. ISCTM February 18 th 2014 Ravi Anand, MD Switzerland Disease Modification in Schizophrenia: Overview of the Issues ISCTM February 18 th 2014 Ravi Anand, MD Switzerland Need for a New Treatment Paradigm in Schizophrenia Sixty years after approval for the

More information

Schizophrenia and schizophrenia-like disorders

Schizophrenia and schizophrenia-like disorders Schizophrenia and schizophrenia-like disorders Dr: Weibo Liu E-mail:liuweibo1020@163.com The Second Affiliated Hospital Zhejiang University College of Medicine Category of psychotic disorders Schizophrenia

More information

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam. Introduction

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam. Introduction CASE REPORT Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam Adeeb Yacoub Andrew Francis Department of Psychiatry and Behavioral Science, School of Medicine,

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

CHAPTER 3. Schizophrenia and Antipsychotic Treatment

CHAPTER 3. Schizophrenia and Antipsychotic Treatment CHAPTER 3 Schizophrenia and Antipsychotic Treatment What is it? It is a severe, chronic, disabling brain disease Considered to have biological origins but exact unknown 1% of population affected Schizophrenia

More information

A. General features of the basal ganglia, one of our 3 major motor control centers:

A. General features of the basal ganglia, one of our 3 major motor control centers: Reading: Waxman pp. 141-146 are not very helpful! Computer Resources: HyperBrain, Chapter 12 Dental Neuroanatomy Suzanne S. Stensaas, Ph.D. April 22, 2010 THE BASAL GANGLIA Objectives: 1. What are the

More information

Basal Ganglia. Today s lecture is about Basal Ganglia and it covers:

Basal Ganglia. Today s lecture is about Basal Ganglia and it covers: Basal Ganglia Motor system is complex interaction between Lower motor neurons (spinal cord and brainstem circuits) and Upper motor neurons (pyramidal and extrapyramidal tracts) plus two main regulators

More information

ACOEM Commercial Driver Medical Examiner Training Program

ACOEM Commercial Driver Medical Examiner Training Program ACOEM Commercial Driver Medical Examiner Training Program Module 7: Psychological Psychological 49 CFR 391.41(b)(9) "A person is physically qualified to drive a commercial motor vehicle if that person

More information